The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.
High-Risk Human Papillomaviral Oncogenes E6 and E7 Target Key Cellular Pathways to Achieve Oncogenesis
Open accessAbstract
Infection with high-risk human papillomavirus (HPV) has been linked to several human cancers, the most prominent of which is cervical cancer. The integration of the viral genome into the host genome is one of the manners in which the viral oncogenes E6 and E7 achieve persistent expression. The most well-studied cellular targets of the viral oncogenes E6 and E7 are p53 and pRb, respectively. However, recent research has demonstrated the ability of these two viral factors to target many more cellular factors, including proteins which regulate epigenetic marks and splicing changes in the cell. These have the ability to exert a global change, which eventually culminates to uncontrolled proliferation and carcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Toll-like receptor recognizes bacterial DNA
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., et al. (2000) · Nature · doi:10.1038/35047123 · Cited by 6,491 · cited 4×
“Canonically, TLR9 is able to recognize unmethylated CpG motifs on double-stranded DNA from viruses such as HPV [156], EBV [157], and HSV [158].”
BackgroundInfluentialThe E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide Perspective
Bosch, F. X., Manos, M. M., Munoz, N., Sherman, M., Jansen, A. M., Peto, J., Schiffman, M. H., Moreno, V., Kurman, R., Shan, K. V., et al. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.11.796 · Cited by 3,370
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
Sheehy, A. M., Gaddis, N. C., Choi, J. D., & Malim, M. H. (2002) · Nature · doi:10.1038/nature00939 · Cited by 2,327
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,054
Dürst, M., Gissmann, L., Ikenberg, H., & zur Hausen, H. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.12.3812 · Cited by 2,025
Papillomavirus infections — a major cause of human cancers
Hausen, H. Z. (1996) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(96)00020-0 · Cited by 1,513
Integrated genomic and molecular characterization of cervical cancer
The Cancer Genome Atlas Research Network (2017) · Nature · doi:10.1038/nature21386 · Cited by 1,479
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women
Joura, E. A., Giuliano, A. R., Iversen, O.-E., Bouchard, C., Mao, C., Mehlsen, J., Moreira, E. D., Ngan, Y., Petersen, L. K., Lazcano-Ponce, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405044 · Cited by 1,433
Recognition of Unique Carboxyl-Terminal Motifs by Distinct PDZ Domains
Songyang, Z., Fanning, A. S., Fu, C., Xu, J., Marfatia, S. M., Chishti, A. H., Crompton, A., Chan, A. C., Anderson, J. M., & Cantley, L. C. (1997) · Science · doi:10.1126/science.275.5296.73 · Cited by 1,385 · cited 1×
“The PBM enables the interaction and subsequent degradation of proteins containing a PDZ domain, which is frequently (but not always) located on the C-terminus of proteins [49].”
BackgroundUBE3A/E6-AP mutations cause Angelman syndrome
Kishino, T., Lalande, M., & Wagstaff, J. (1997) · Nature Genetics · doi:10.1038/ng0197-70 · Cited by 1,298
Toll-like Receptor 9–mediated Recognition of Herpes Simplex Virus-2 by Plasmacytoid Dendritic Cells
Lund, J., Sato, A., Akira, S., Medzhitov, R., & Iwasaki, A. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030162 · Cited by 1,198
Worldwide burden of cervical cancer in 2008
Arbyn, M., Castellsagué, X., de Sanjosé, S., Bruni, L., Saraiya, M., Bray, F., & Ferlay, J. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr015 · Cited by 1,130
E2F integrates cell cycle progression with DNA repair, replication, and G 2 /M checkpoints
Ren, B., Cam, H., Takahashi, Y., Volkert, T., Terragni, J., Young, R. A., & Dynlacht, B. D. (2002) · Genes & Development · doi:10.1101/gad.949802 · Cited by 1,125
A SARCOMA OF THE FOWL TRANSMISSIBLE BY AN AGENT SEPARABLE FROM THE TUMOR CELLS
Rous, P. (1911) · Journal of Experimental Medicine · doi:10.1084/jem.13.4.397 · Cited by 1,051
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
Ferrara, N., Hillan, K. J., & Novotny, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.132 · Cited by 977
Münger, K., Werness, B. A., Dyson, N., Phelps, W. C., Harlow, E., & Howley, P. M. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08594.x · Cited by 964
The Anaphase-Promoting Complex
Peters, J.-M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00540-3 · Cited by 909
Huibregtse, J. M., Scheffner, M., & Howley, P. M. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04990.x · Cited by 879
Nucleotide deficiency promotes genomic instability in early stages of cancer development
Bester, A. C., Roniger, M., Oren, Y. S., Im, M. M., Sarni, D., Chaoat, M., Bensimon, A., Zamir, G., Shewach, D. S., & Kerem, B. (2011) · Cell · doi:10.1016/j.cell.2011.03.044 · Cited by 858
MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
Gabay, M., Li, Y., & Felsher, D. W. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014241 · Cited by 818
A review of clinical trials of human papillomavirus prophylactic vaccines
Schiller, J. T., Castellsagué, X., & Garland, S. M. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.04.108 · Cited by 747
Tewari, K. S., Sill, M. W., Penson, R. T., Huang, H., Ramondetta, L. M., Landrum, L. M., Oaknin, A., Reid, T. J., Leitao, M. M., Michael, H. E., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31607-0 · Cited by 684
Centrosome defects and genetic instability in malignant tumors.
Pihan, G. A., Purohit, A., Wallace, J., Knecht, H., Woda, B. A., Quesenberry, P. J., & Doxsey, S. (1998) · PubMed · Cited by 592
Jeon, S., Allen-Hoffmann, B. L., & Lambert, P. F. (1995) · Journal of Virology · doi:10.1128/jvi.69.5.2989-2997.1995 · Cited by 582
Nishioka, K., Chuikov, S., Sarma, K., Erdjument-Bromage, H., Allis, C. D., Tempst, P., & Reinberg, D. (2002) · Genes & Development · doi:10.1101/gad.967202 · Cited by 557
Akt-Mediated Phosphorylation of EZH2 Suppresses Methylation of Lysine 27 in Histone H3
Cha, T.-L., Zhou, B. P., Xia, W., Wu, Y., Yang, C.-C., Chen, C.-T., Ping, B., Otte, A. P., & Hung, M.-C. (2005) · Science · doi:10.1126/science.1118947 · Cited by 548
HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women
Gillison, M. L., Chaturvedi, A. K., & Lowy, D. R. (2008) · Cancer · doi:10.1002/cncr.23764 · Cited by 517
Structure of the E6/E6AP/p53 complex required for HPV-mediated degradation of p53
Martinez-Zapien, D., Ruiz, F. X., Poirson, J., Mitschler, A., Ramirez, J., Forster, A., Cousido-Siah, A., Masson, M., Pol, S. V., Podjarny, A., et al. (2016) · Nature · doi:10.1038/nature16481 · Cited by 483
Duensing, S. M., & Münger, K. (2002) · PubMed · Cited by 464
Dougherty, M. K., & Morrison, D. K. (2004) · Journal of Cell Science · doi:10.1242/jcs.01171 · Cited by 461
Molecular biology of Bax and Bak activation and action
Westphal, D., Dewson, G., Czabotar, P. E., & Kluck, R. M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.12.019 · Cited by 453
DNA tumor virus oncogenes antagonize the cGAS-STING DNA-sensing pathway
Lau, L., Gray, E. E., Brunette, R. L., & Stetson, D. B. (2015) · Science · doi:10.1126/science.aab3291 · Cited by 453
Human APOBEC3F Is Another Host Factor That Blocks Human Immunodeficiency Virus Type 1 Replication
Zheng, Y.-H., Irwin, D., Kurosu, T., Tokunaga, K., Sata, T., & Peterlin, B. M. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6073-6076.2004 · Cited by 435
Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T., & Ishibashi, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.21.11612 · Cited by 428
Polo-like kinases: a team that plays throughout mitosis
Glover, D. M., Hagan, I. M., & Tavares, Á. A. M. (1998) · Genes & Development · doi:10.1101/gad.12.24.3777 · Cited by 424
Human papillomavirus-related oropharyngeal cancer
Taberna, M., Mena, M., Pavón, M. A., Alemany, L., Gillison, M. L., & Mesía, R. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx304 · Cited by 399
Duensing, S., Lee, L. Y., Duensing, A., Basile, J., Piboonniyom, S.-O., Gonzalez, S., Crum, C. P., & Münger, K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170093297 · Cited by 397
Nakagawa, S., & Huibregtse, J. M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.21.8244-8253.2000 · Cited by 382
Donovan, B., Franklin, N., Guy, R., Grulich, A. E., Regan, D. G., Ali, H., Wand, H., & Fairley, C. K. (2011) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70225-5 · Cited by 380
Hasan, U. A., Bates, E., Takeshita, F., Biliato, A., Accardi, R., Bouvard, V., Mansour, M., Vincent, I., Gissmann, L., Iftner, T., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.5.3186 · Cited by 380
The role of integration in oncogenic progression of HPV-associated cancers
McBride, A. A., & Warburton, A. (2017) · PLOS Pathogens · doi:10.1371/journal.ppat.1006211 · Cited by 376
Polo-like kinases: positive regulators of cell division from start to finish
Nigg, E. A. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80121-x · Cited by 344
Lawson, J. S., Salmons, B., & Glenn, W. K. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00001 · Cited by 340
Hultquist, J. F., Lengyel, J. A., Refsland, E. W., LaRue, R. S., Lackey, L., Brown, W. L., & Harris, R. S. (2011) · Journal of Virology · doi:10.1128/jvi.05238-11 · Cited by 338
Infectious agents and cancer: criteria for a causal relation
Pagano, J. S., Blaser, M., Buendia, M.-A., Damania, B., Khalili, K., Raab-Traub, N., & Roizman, B. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.06.009 · Cited by 337
Fischer, M., Grossmann, P., Padi, M., & DeCaprio, J. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw523 · Cited by 330
Egawa, N., & Doorbar, J. (2017) · Virus Research · doi:10.1016/j.virusres.2016.12.017 · Cited by 330
The biological properties of E6 and E7 oncoproteins from human papillomaviruses
Ghittoni, R., Accardi, R., Hasan, U., Gheit, T., Sylla, B., & Tommasino, M. (2010) · Virus Genes · doi:10.1007/s11262-009-0412-8 · Cited by 322
Ewald, S. E., Engel, A., Lee, J., Wang, M., Bogyo, M., & Barton, G. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20100682 · Cited by 315
Thierry, F., & Yaniv, M. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02662.x · Cited by 292
McLaughlin-Drubin, M. E., Crum, C. P., & Münger, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009933108 · Cited by 288
Zimmermann, H., Degenkolbe, R., Bernard, H.-U., & O’Connor, M. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6209-6219.1999 · Cited by 282
Gewin, L., Myers, H., Kiyono, T., & Galloway, D. A. (2004) · Genes & Development · doi:10.1101/gad.1214704 · Cited by 277
Straight, S. W., Hinkle, P. M., Jewers, R. J., & McCance, D. J. (1993) · Journal of Virology · doi:10.1128/jvi.67.8.4521-4532.1993 · Cited by 271
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
Brehm, A., Nielsen, S. J., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2449 · Cited by 267
Glaunsinger, B. A., Lee, S. S., Thomas, M., Banks, L., & Javier, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203906 · Cited by 264
Bromodomain Protein BRD4 Is a Transcriptional Repressor of Autophagy and Lysosomal Function
Sakamaki, J.-I., Wilkinson, S., Hahn, M., Tasdemir, N., O’Prey, J., Clark, W., Hedley, A., Nixon, C., Long, J. S., New, M., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.027 · Cited by 249
Viral oncoproteins target the DNA methyltransferases
Burgers, W. A., Blanchon, L., Pradhan, S., Launoit, Y. D., Kouzarides, T., & Fuks, F. (2007) · Oncogene · doi:10.1038/sj.onc.1209950 · Cited by 242
MYC and the Control of Apoptosis
McMahon, S. B. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014407 · Cited by 240
Veldman, T., Horikawa, I., Barrett, J. C., & Schlegel, R. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4467-4472.2001 · Cited by 237
Jones, D. L., Thompson, D. A., & Münger, K. (1997) · Virology · doi:10.1006/viro.1997.8851 · Cited by 231
Nguyen, M. L., Nguyen, M. M., Lee, D., Griep, A. E., & Lambert, P. F. (2003) · Journal of Virology · doi:10.1128/jvi.77.12.6957-6964.2003 · Cited by 229
MacLean, G., Abu-Abed, S., Dollé, P., Tahayato, A., Chambon, P., & Petkovich, M. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(01)00463-4 · Cited by 224
Honegger, A., Schilling, D., Bastian, S., Sponagel, J., Kuryshev, V., Sültmann, H., Scheffner, M., Hoppe-Seyler, K., & Hoppe-Seyler, F. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004712 · Cited by 222
Veldman, T., Liu, X., Yuan, H., & Schlegel, R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1435900100 · Cited by 214
Hu, Z., Yu, L., Zhu, D., Ding, W., Wang, X., Zhang, C., Wang, L., Jiang, X., Shen, H., He, D., et al. (2014) · BioMed Research International · doi:10.1155/2014/612823 · Cited by 211
Brd4 links chromatin targeting to HPV transcriptional silencing
Wu, S.-Y., Lee, A.-Y., Hou, S. Y., Kemper, J. K., Erdjument-Bromage, H., Tempst, P., & Chiang, C.-M. (2006) · Genes & Development · doi:10.1101/gad.1448206 · Cited by 210
Oh, S. T., Kyo, S., & Laimins, L. A. (2001) · Journal of Virology · doi:10.1128/jvi.75.12.5559-5566.2001 · Cited by 201
Shay, J. W., Wright, W. E., Brasiskyte, D., & Haegen, B. A. (1993) · PubMed · Cited by 201
Duensing, S. M., Duensing, A. U., Crum, C. P., & Münger, K. (2001) · PubMed · Cited by 200
Vieira, V. C., Leonard, B., White, E. A., Starrett, G. J., Temiz, N. A., Lorenz, L. D., Lee, D., Soares, M. A., Lambert, P. F., Howley, P. M., et al. (2014) · mBio · doi:10.1128/mbio.02234-14 · Cited by 198
RNA Interference of Human Papillomavirus Type 18 E6 and E7 Induces Senescence in HeLa Cells
Hall, A. H. S., & Alexander, K. A. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.6066-6069.2003 · Cited by 196
Hasan, U. A., Zannetti, C., Parroche, P., Goutagny, N., Malfroy, M., Roblot, G., Carreira, C., Hussain, I., Müller, M., Taylor-Papadimitriou, J., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122394 · Cited by 191
Spangle, J. M., & Münger, K. (2010) · Journal of Virology · doi:10.1128/jvi.00974-10 · Cited by 189
APOBEC3A Functions as a Restriction Factor of Human Papillomavirus
Warren, C. J., Xu, T., Guo, K., Griffin, L. M., Westrich, J. A., Lee, D., Lambert, P. F., Santiago, M. L., & Pyeon, D. (2015) · Journal of Virology · doi:10.1128/jvi.02383-14 · Cited by 186
Filippova, M., Song, H., Connolly, J. L., Dermody, T. S., & Duerksen-Hughes, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200113200 · Cited by 186
HPV E6 protein interacts physically and functionally with the cellular telomerase complex
Liu, X., Dakic, A., Zhang, Y., Dai, Y., Chen, R., & Schlegel, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906357106 · Cited by 179
Gross-Mesilaty, S., Reinstein, E., Bercovich, B., Tobias, K. E., Schwartz, A. L., Kahana, C., & Ciechanover, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8058 · Cited by 177
Human papilloma virus is associated with breast cancer
Heng, B., Glenn, W. K., Ye, Y., Tran, B., Delprado, W., Lutze-Mann, L., Whitaker, N. J., & Lawson, J. S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605282 · Cited by 176
Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein
Laurson, J., Khan, S., Chung, R., Cross, K., & Raj, K. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq027 · Cited by 172
Thomas, M., & Banks, L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-6-1513 · Cited by 166
Couturier, J., Sastre‐Garau, X., Schneider‐Maunoury, S., Labib, A., & Orth, G. (1991) · Journal of Virology · doi:10.1128/jvi.65.8.4534-4538.1991 · Cited by 165
Longworth, M. S., & Laimins, L. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.7.3533-3541.2004 · Cited by 163
TLR9 Contributes to the Recognition of EBV by Primary Monocytes and Plasmacytoid Dendritic Cells
Fiola, S., Gosselin, D., Takada, K., & Gosselin, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903736 · Cited by 162
Sartor, M. A., Dolinoy, D. C., Jones, T. R., Colacino, J. A., Prince, M. E. P., Carey, T. E., & Rozek, L. S. (2011) · Epigenetics · doi:10.4161/epi.6.6.16216 · Cited by 159
Karim, R., Meyers, C., Backendorf, C., Ludigs, K., Offringa, R., van Ommen, G.-J. B., Melief, C. J. M., van der Burg, S. H., & Boer, J. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017848 · Cited by 158
Zhang, B., Chen, W., & Roman, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510012103 · Cited by 156
Zhang, Y., Koneva, L. A., Virani, S., Arthur, A. E., Virani, A., Hall, P. B., Warden, C., Carey, T. E., Chepeha, D. B., Prince, M. E., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0323 · Cited by 156
Reiser, J., Hurst, J., Voges, M., Krauss, P., Münch, P., Iftner, T., & Stubenrauch, F. (2011) · Journal of Virology · doi:10.1128/jvi.05279-11 · Cited by 155
Do HPV-negative cervical carcinomas exist?
Walboomers, J. M. M., & Meijer, C. J. L. M. (1997) · The Journal of Pathology · Cited by 152
Garnett, T. O., Filippova, M., & Duerksen-Hughes, P. J. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401886 · Cited by 152
Filippova, M., Parkhurst, L., & Duerksen-Hughes, P. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401172200 · Cited by 149
Myc Goes Global: New Tricks for an Old Oncogene
Knoepfler, P. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0426 · Cited by 147
Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein
Menges, C. W., Baglia, L. A., Lapoint, R., & McCance, D. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0499 · Cited by 145
McMurray, H. R., & McCance, D. J. (2003) · Journal of Virology · doi:10.1128/jvi.77.18.9852-9861.2003 · Cited by 143
Demers, G. W., Halbert, C. L., & Galloway, D. A. (1994) · Virology · doi:10.1006/viro.1994.1019 · Cited by 141
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Prevalence of deletions of YY1‐binding sites in episomal HPV 16 DNA from cervical cancers
Dong, X., Stubenrauch, F., Beyer‐Finkler, E., & Pfister, H. (1994) · International Journal of Cancer · doi:10.1002/ijc.2910580609 · Cited by 140
HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53
Kwok (2010) · Oncology Reports · doi:10.3892/or_00001023 · Cited by 140
Epigenetic Silencing of Interferon-κ in Human Papillomavirus Type 16–Positive Cells
Rincón‐Orozco, B., Halec, G., Rosenberger, S., Muschik, D., Nindl, I., Bachmann, A., Ritter, T. M., Dondog, B., Ly, R., Bosch, F. X., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0550 · Cited by 138
Human Papillomavirus Quadrivalent (types 6, 11, 16, 18) Recombinant Vaccine (Gardasil??)
Siddiqui, M. A. A., & Perry, C. M. (2006) · Drugs · doi:10.2165/00003495-200666090-00008 · Cited by 137
Chaiwongkot, A., Vinokurova, S., Pientong, C., Ekalaksananan, T., Kongyingyoes, B., Kleebkaow, P., Chumworathayi, B., Patarapadungkit, N., Reuschenbach, M., & Doeberitz, M. V. K. (2012) · International Journal of Cancer · doi:10.1002/ijc.27906 · Cited by 136
Cicchini, L., Westrich, J. A., Xu, T., Vermeer, D. W., Berger, J., Clambey, E. T., Lee, D., Song, J. I., Lambert, P. F., Greer, R. O., et al. (2016) · mBio · doi:10.1128/mbio.00270-16 · Cited by 133
TALEN-mediated targeting of HPV oncogenes ameliorates HPV-related cervical malignancy
Hu, Z., Ding, W., Zhu, D., Yu, L., Jiang, X., Wang, X., Zhang, C., Wang, L., Ji, T., Liu, D., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci78206 · Cited by 132
Watson, R. A., Thomas, M., Banks, L., & Roberts, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00809 · Cited by 129
Lechner, M., Fenton, T. R., West, J., Wilson, G. A., Feber, A., Henderson, S. R., Thirlwell, C., Dibra, H. K., Jay, A., Butcher, L. M., et al. (2013) · Genome Medicine · doi:10.1186/gm419 · Cited by 128
Lee, C., & Laimins, L. A. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12366-12377.2004 · Cited by 125
Genther Williams, S. M., Disbrow, G. L., Schlegel, R., Lee, D., Threadgill, D. W., & Lambert, P. F. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0083 · Cited by 125
Kranjec, C., & Banks, L. (2010) · Journal of Virology · doi:10.1128/jvi.01756-10 · Cited by 122
Jha, S., Vande Pol, S., Banerjee, N. S., Dutta, A. B., Chow, L. T., & Dutta, A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.020 · Cited by 120
Self-citationHuman papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway
Fischer, M., Uxa, S., Stanko, C., Magin, T. M., & Engeland, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-02831-9 · Cited by 119
Human papillomavirus type 16 E7 oncoprotein associates with E2F6
McLaughlin-Drubin, M. E., Huh, K.-W., & Münger, K. (2008) · Journal of Virology · doi:10.1128/jvi.00579-08 · Cited by 116
Hyland, P. L., McDade, S. S., McCloskey, R., Dickson, G. J., Arthur, K., McCance, D. J., & Patel, D. (2011) · Journal of Virology · doi:10.1128/jvi.00160-11 · Cited by 112
Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression
Warren, C. J., Westrich, J. A., Doorslaer, K. V., & Pyeon, D. (2017) · Viruses · doi:10.3390/v9080233 · Cited by 112
Giannini, S. L., Hubert, P., Doyen, J., Boniver, J., & Delvenne, P. (2001) · International Journal of Cancer · doi:10.1002/ijc.10084 · Cited by 111
Kelley, M. L., Keiger, K., Lee, C. J., & Huibregtse, J. M. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3737-3747.2005 · Cited by 110
Quaas, M., Müller, G. A., & Engeland, K. (2012) · Cell Cycle · doi:10.4161/cc.22917 · Cited by 107
Bhattacharjee, B., & Sengupta, S. (2006) · Virology · doi:10.1016/j.virol.2006.06.018 · Cited by 107
Pim, D., Thomas, M., Javier, R., Gardiol, D., & Banks, L. (2000) · Oncogene · doi:10.1038/sj.onc.1203374 · Cited by 106
Basile, J. R., Zacny, V. L., & Münger, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010505200 · Cited by 106
Activation of the Enhancer of Zeste Homologue 2 Gene by the Human Papillomavirus E7 Oncoprotein
Holland, D., Hoppe-Seyler, K., Schuller, B., Lohrey, C., Maroldt, J., Dürst, M., & Hoppe-Seyler, F. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1134 · Cited by 99
Association of High Risk Human Papillomavirus and Breast cancer: A UK based Study
Salman, N. A., Davies, G., Majidy, F., Shakir, F., Akinrinade, H., Perumal, D., & Ashrafi, G. H. (2017) · Scientific Reports · doi:10.1038/srep43591 · Cited by 98
HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs
Longworth, M. S., Wilson, R., & Laimins, L. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600651 · Cited by 96
The E5 gene of HPV-16 enhances keratinocyte immortalization by full-length DNA
Stöppler, M. C., Straight, S. W., Tsao, G., Schlegel, R., & Mccance, D. J. (1996) · Virology · doi:10.1006/viro.1996.0475 · Cited by 93
Patel, D., Incassati, A., Wang, N., & McCance, D. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2917 · Cited by 93
Seavey, S. E., Holubar, M. K., Saucedo, L. J., & Perry, M. E. (1999) · Journal of Virology · doi:10.1128/jvi.73.9.7590-7598.1999 · Cited by 88
Shukla, S., Bharti, A. C., Hussain, S., Mahata, S., Hedau, S. T., Kailash, U., Kashyap, V., Bhambhani, S., Roy, M., Batra, S., et al. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0617-1 · Cited by 84
Transcriptional Repression of E-Cadherin by Human Papillomavirus Type 16 E6
D'Costa, Z. J., Jolly, C., Androphy, E. J., Mercer, A., Matthews, C. M., & Hibma, M. H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048954 · Cited by 83
B-MYB Is Required for Recovery from the DNA Damage–Induced G2 Checkpoint in p53 Mutant Cells
Mannefeld, M., Klassen, E., & Gaubatz, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4156 · Cited by 82
Boon, S. S., & Banks, L. (2012) · Journal of Virology · doi:10.1128/jvi.02074-12 · Cited by 82
The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription
Hsu, C.-H., Peng, K.-L., Jhang, H.-C., Lin, C.-H., Wu, S.-Y., Chiang, C.-M., Lee, S.-C., Yu, W., & Juan, L.-J. (2011) · Oncogene · doi:10.1038/onc.2011.415 · Cited by 82
O’Connor, M. J., Zimmermann, H., Nielsen, S. J., Bernard, H., & Kouzarides, T. (1999) · Journal of Virology · doi:10.1128/jvi.73.5.3574-3581.1999 · Cited by 81
Identification and Validation of Human Papillomavirus Encoded microRNAs
Qian, K., Pietilä, T., Rönty, M. J., Michon, F., Frilander, M. J., Ritari, J., Tarkkanen, J., Paulin, L. G., Auvinen, P., & Auvinen, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070202 · Cited by 78
Wasson, C. W., Morgan, E. L., Müller, M., Ross, R. L., Hartley, M., Roberts, S., & Macdonald, A. (2017) · Oncotarget · doi:10.18632/oncotarget.21658 · Cited by 78
Richard, C., Lannér, C., Naryzhny, S., Sherman, L., Lee, H., Lambert, P. F., & Zehbe, I. (2010) · Oncogene · doi:10.1038/onc.2010.93 · Cited by 77
Human Papillomavirus 16 E6 Upregulates APOBEC3B via the TEAD Transcription Factor
Mori, S., Takeuchi, T., Ishii, Y., Yugawa, T., Kiyono, T., Nishina, H., & Kukimoto, I. (2017) · Journal of Virology · doi:10.1128/jvi.02413-16 · Cited by 75
Role of the host restriction factor APOBEC3 on papillomavirus evolution
Warren, C. J., Doorslaer, K. V., Pandey, A., Espinosa, J. M., & Pyeon, D. (2015) · Virus Evolution · doi:10.1093/ve/vev015 · Cited by 74
Fischer, M., Quaas, M., Wintsche, A., Müller, G. A., & Engeland, K. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt849 · Cited by 70
Delury, C. P., Marsh, E. K., James, C. D., Boon, S. S., Banks, L., Knight, G. L., & Roberts, S. (2013) · Journal of Virology · doi:10.1128/jvi.01234-13 · Cited by 67
E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60
Subbaiah, V. K., Zhang, Y., Rajagopalan, D., Abdullah, L. N., Yeo-Teh, N. S. L., Tomaić, V., Banks, L., Myers, M. P., Chow, E. K., & Jha, S. (2015) · Oncogene · doi:10.1038/onc.2015.268 · Cited by 66
Self-citationMapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin‐proteasome system
Poirson, J., Biquand, É., Straub, M., Cassonnet, P., Nominé, Y., Jones, L. M., van der Werf, S., Travé, G., Zanier, K., Jacob, Y., et al. (2017) · FEBS Journal · doi:10.1111/febs.14193 · Cited by 66
Nguyen, M. L., Song, S., Liem, A., Androphy, E. J., Liu, Y., & Lambert, P. F. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13039-13048.2002 · Cited by 65
Degradation of hDlg and MAGIs by human papillomavirus E6 is E6-AP-independent
Grm, H. Š., & Banks, L. (2004) · Journal of General Virology · doi:10.1099/vir.0.80035-0 · Cited by 64
Caberg, J., Hubert, P., Herman, L., Herfs, M. F., Roncarati, P., Boniver, J., & Delvenne, P. (2008) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0522-5 · Cited by 64
Westrich, J. A., Warren, C. J., Klausner, M. J., Guo, K., Liu, C.-W., Santiago, M. L., & Pyeon, D. (2018) · Journal of Virology · doi:10.1128/jvi.01318-17 · Cited by 60
Shukla, S., Mahata, S., Shishodia, G., Pande, S., Verma, G., Hedau, S. T., Bhambhani, S., Kumari, A., Batra, S., Basir, S. F., et al. (2014) · PubMed Central · Cited by 59
Rashid, N. N., Yusof, R., & Watson, R. J. (2011) · Journal of General Virology · doi:10.1099/vir.0.035352-0 · Cited by 55
Bodaghi, S., Jia, R., & Zheng, Z. (2009) · Virology · doi:10.1016/j.virol.2008.12.037 · Cited by 54
Vogt, M., Butz, K., Dymalla, S., Semzow, J., & Hoppe-Seyler, F. (2006) · Oncogene · doi:10.1038/sj.onc.1209429 · Cited by 54
HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity
Wang, Y.-W., Chang, H., Lin, C.-H., & Yu, W. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.09.006 · Cited by 51
Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer
Jung, H. S., Rajasekaran, N., Ju, W., & Shin, Y. K. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm4051126 · Cited by 51
Viral infections and breast cancer – A current perspective
Gannon, O. M., Antonsson, A., Bennett, I., & Saunders, N. A. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.076 · Cited by 51
Zhang, B., Laribee, R. N., Klemsz, M. J., & Roman, A. (2004) · Virology · doi:10.1016/j.virol.2004.08.009 · Cited by 50
Zhang, Y., Dakic, A., Chen, R., Dai, Y., Schlegel, R., & Liu, X. (2017) · Oncotarget · doi:10.18632/oncotarget.22036 · Cited by 48
Stable and unstable pools of Myc protein exist in human cells
Tworkowski, K. A., Salghetti, S. E., & Tansey, W. P. (2002) · Oncogene · doi:10.1038/sj.onc.1205976 · Cited by 45
Yoshimatsu, Y., Nakahara, T., Tanaka, K., Inagawa, Y., Narisawa‐Saito, M., Yugawa, T., Ohno, S., Fujita, M., Nakagama, H., & Kiyono, T. (2017) · Cancer Science · doi:10.1111/cas.13264 · Cited by 44
Lea, J. S., Sunaga, N., Sato, M., Kalahasti, G., Miller, D. S., Minna, J. D., & Muller, C. Y. (2007) · Reproductive Sciences · doi:10.1177/1933719106298189 · Cited by 42
Reduced gene expression of E-cadherin and associated catenins in human cervical carcinoma cell lines
Denk, C., Hülsken, J., & Schwarz, E. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00308-x · Cited by 40
DeCaprio, J. A. (2013) · Oncogene · doi:10.1038/onc.2013.449 · Cited by 38
Yin, F., Wang, N., Bi, X., Yu, X., Xu, X., Wang, Y.-L., Zhao, C., Luo, B., & Wang, Y. (2016) · Virology Journal · doi:10.1186/s12985-016-0515-5 · Cited by 37
Prediction of conserved microRNAs from skin and mucosal human papillomaviruses
Gu, W., An, J., Ye, P., Zhao, K., & Antonsson, A. (2011) · Archives of Virology · doi:10.1007/s00705-011-0974-3 · Cited by 34
TIP60 represses telomerase expression by inhibiting Sp1 binding to the TERT promoter
Rajagopalan, D., Pandey, A. K., Xiuzhen, M. C., Lee, K. K., Hora, S., Zhang, Y., Chua, B. H., Kwok, H. S., Bhatia, S. S., Deng, L., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006681 · Cited by 33
Self-citationSTK31 Maintains the Undifferentiated State of Colon Cancer Cells
Fok, K. L., Chung, C. M., Yi, S. Q., Jiang, X., Sun, X., Chen, H., Chen, Y., Kung, H., Tao, Q., Diao, R., et al. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs246 · Cited by 32
Murata, M., Kojima, T., Yamamoto, T., Go, M., Takano, K., Chiba, H., Tokino, T., & Sawada, N. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-1017-0 · Cited by 31
Chujan, S., Kitkumthorn, N., Siriangkul, S., & Mutirangura, A. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.18.7971 · Cited by 29
Prevalence of mucosal and cutaneous human papillomavirus in Moroccan breast cancer
Elamrani, A., Gheit, T., Benhessou, M., McKay‐Chopin, S., Attaleb, M., Sahraoui, S., Mzibri, M. E., Corbex, M. A., Tommasino, M., & Khyatti, M. (2018) · Papillomavirus Research · doi:10.1016/j.pvr.2018.04.003 · Cited by 27
Wang, T., Zeng, X., Li, W., Zhu, H., Wang, G., Liu, X., Lv, Y., Wu, J., Zhuang, X., Zhang, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090343 · Cited by 18
Expression of the HPV18/E6 oncoprotein induces DNA damage
Cortés-Gutiérrez, E. I., García-Vielma, C., Aguilar‐Lemarroy, A., Vallejo‐Ruiz, V., Piña‐Sánchez, P., Zapata‐Benavides, P., & Gosálvez, J. (2017) · European Journal of Histochemistry · doi:10.4081/ejh.2017.2773 · Cited by 13
p21 governs p53's repressive side
Fischer, M. (2016) · Cell Cycle · doi:10.1080/15384101.2016.1205393 · Cited by 12 · cited 1×
“Interestingly, E7 can also target cyclin-dependent kinase (CDK) inhibitor p21, a crucial target of p53 required for its activity [150,151].”
BackgroundRashid, N. N., Yusof, R., & Watson, R. J. (2013) · Acta Virologica · doi:10.4149/av_2013_04_447 · Cited by 12
Xu, J., Fang, Y., Qin, J., Chen, X., Liang, X., Xie, X., & Lü, W. (2016) · FEBS Letters · doi:10.1002/1873-3468.12486 · Cited by 11
(1992) · PubMed
Cited by
Neoantigens: promising targets for cancer therapy
Xie, N., Shen, G., Gao, W., Huang, Z., Huang, C., & Fu, L. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01270-x · Cited by 1,020
Cervical cancer therapies: Current challenges and future perspectives
Burmeister, C. A., Khan, S. F., Schäfer, G., Mbatani, N., Adams, T., Moodley, J., & Prince, S. (2022) · Tumour Virus Research · doi:10.1016/j.tvr.2022.200238 · Cited by 474
Human Papillomavirus Vaccine Efficacy and Effectiveness against Cancer
Kamolratanakul, S., & Pitisuttithum, P. (2021) · Vaccines · doi:10.3390/vaccines9121413 · Cited by 263
Metadata
- Authors
- Yeo-Teh, N. S. L., Ito, Y., & Jha, S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-06-08
- Volume
- 19
- Issue
- 6
- Pages
- 1706
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2806339429
- Cited by
- 273
- References
- 174
- FWCI
- 13.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.